ULBI Q2 2026: Backlog Soars 39% to $117.5M Amid Margin Gains and New Product Momentum
Ultralife Corporation delivered a robust quarter marked by record backlog growth and significant gross margin expansion driven by favorable product mix and tariff refunds. The company’s strategic investments in communication systems and battery innovations are beginning to translate into commercial traction and operational improvements. With a diversified backlog and ongoing product launches, Ultralife is positioned for sustained revenue growth and margin enhancement into 2027.
Summary
- Backlog Expansion: Record backlog growth reflects strong demand and broadening product portfolio.
- Margin Improvement Efforts: Operational initiatives and tariff refunds materially boosted gross margins.
- Strategic Product Development: New communication and battery products underpin long-term growth prospects.
Business Overview
Ultralife Corporation is a diversified manufacturer specializing in portable power solutions and communication systems, primarily serving government defense and commercial markets. The company operates two main segments: battery and energy products, which provide advanced batteries for medical, safety, and defense applications, and communication systems, delivering ruggedized radio amplifiers, vehicle mounts, and computing solutions for tactical environments.
Performance Analysis
In Q2 2026, Ultralife reported consolidated revenues of $47.9 million, slightly below the prior year’s $48.6 million, reflecting a 5% increase in government defense sales offset by a 4.7% decline in commercial revenues. The battery and energy segment, comprising 92% of total revenues, experienced a 3.7% decrease primarily due to geopolitical-driven weakness in oil and gas commercial sales, partially offset by a 7.2% rise in medical battery sales. The communication systems segment delivered a notable 39.3% revenue increase, benefiting from timing of orders and new product introductions.
Gross profit rose 19.5% year-over-year to $13.9 million, lifting the consolidated gross margin by 500 basis points to 28.9%. This margin improvement was driven by a favorable sales mix in both segments and a $1.1 million net refund of previously accrued tariffs, which alone accounted for 230 basis points of the margin expansion. Excluding the tariff refund, gross margin still improved to 26.6%, underscoring operational progress. Operating expenses increased 10.6%, largely due to higher new product development investments and one-time litigation and consulting costs aimed at accelerating margin gains. Operating income rose to $3.4 million, with operating margin improving to 7.2% from 4.7% in the prior year quarter.
- Backlog Growth and Composition: Backlog reached a record $117.5 million, up 39% year-over-year, with over $14 million attributable to products launched within the past year, signaling strong future revenue visibility.
- Operational Efficiency Initiatives: Newark and Raynham plants are delivering early gross margin benefits through scrap reduction, lean manufacturing, and automation projects expected to generate $600,000 to $800,000 in annual savings.
- Commercial Expansion in Communication Systems: New products like StrikeHub and ruggedized computing solutions are advancing through commercialization, supported by a growing opportunity funnel and customer engagement.
Overall, Ultralife’s performance reflects a business in transition, with legacy commercial softness balanced by defense demand and new product-driven growth. The robust backlog and margin initiatives provide a foundation for improved profitability and revenue growth in the coming quarters.
Executive Commentary
"We continue to build a strong and growing backlog supported by an expanding product portfolio as recent product developments transition from development into commercialization. Our communication systems business is gaining momentum supported by multiple new product releases, a growing opportunity funnel, and active development programs focused on expanding revenue and improving business stability."
Mike Manna, President and CEO
"During Q2, we showcased our new StrikeHub product line at Special Operations Week and HPE Discover. StrikeHub provides vehicle mounting, network switching, power, and UPS to support edge compute solutions targeting Special Operations Forces and next-generation command and control applications."
Mike Manna, President and CEO
Strategic Positioning
1. Accelerating Communication Systems Revenue Capture
Ultralife is actively commercializing several new communication products, including the StrikeHub vehicle-mounted edge compute platform and ruggedized computing solutions integrating Hewlett Packard Enterprise servers. These offerings target specialized defense programs such as Special Operations Forces and the US Army’s Next Gen Command and Control. Early orders and partner collaborations position this segment for profitable baseline revenue within the next year, diversifying Ultralife’s revenue base beyond batteries.
2. Driving Gross Margin Improvement in Battery and Energy Segment
Focused operational improvements at Newark and Raynham manufacturing facilities are addressing historic margin inefficiencies. Initiatives such as scrap reduction in the largest margin-impacting product line and supply chain adjustments are expected to yield annual savings of $600,000 to $800,000. Lean manufacturing and automation projects aim to increase throughput and quality, supporting anticipated 30% growth in customer demand and cell consumption over the next year.
3. Vertical Integration and Product Innovation
The acquisition of Electric Chem enables Ultralife to integrate proprietary battery cells into its pack assemblies, enhancing product differentiation and expanding addressable markets. Growing demand for water-based drone battery solutions exemplifies this strategy. Additionally, new thin cell technology platforms for medical wearables and asset tracking are advancing, supported by a strengthening sales pipeline and multiple OEM development programs.
4. Brand Consolidation Under Ultralife Master Brand
To clarify market positioning and customer messaging, Ultralife is consolidating its sub-brands under a unified master brand. This effort, scheduled for completion by year-end, aims to reinforce Ultralife’s leadership in critical RF and portable power products, enhancing brand equity and market recognition.
5. Sustained Investment in Product Development
Ultralife continues to invest heavily in new product development across both segments. Planned launches include advanced amplifiers compatible with modern waveforms, vehicle radio mounts integrating multiple platforms, and the Crescent wearable edge compute solution. On the battery side, conformal batteries for soldier systems and rechargeable power packs for remote surveillance are progressing toward commercialization, supporting multi-year growth trajectories.
Key Considerations
Ultralife’s Q2 results underscore the company’s strategic transition from legacy commercial reliance toward a more diversified and technologically advanced portfolio. The following considerations are essential for investors:
- Backlog Quality and Visibility: The 39% year-over-year backlog increase, including $14 million from recent product launches, provides strong near-term revenue visibility and reflects successful commercialization efforts.
- Margin Sustainability: While tariff refunds boosted gross margins this quarter, operational improvements indicate that underlying margin expansion is achievable and sustainable.
- Commercial Segment Headwinds: Continued softness in oil and gas-related commercial battery sales highlights geopolitical risks and the importance of diversifying commercial end markets.
- Investment in Growth Areas: Increased new product development spending and vertical integration efforts demonstrate management’s commitment to innovation and long-term growth.
- Brand Realignment Impact: The consolidation under the Ultralife Master brand should streamline customer communications but requires execution to translate into tangible market advantages.
Risks
Ultralife faces risks including potential delays in new product commercialization, geopolitical factors affecting commercial sales, and the challenge of converting backlog into consistent revenue growth. Supply chain disruptions and competitive pressures in both battery and communication segments could also impact margins and market share. Additionally, the execution of operational improvement initiatives is critical to sustaining margin gains beyond one-time tariff refunds.
Forward Outlook
For Q3 2026, Ultralife anticipates continued backlog growth, with CEO Mike Manna noting that orders have pushed backlog close to $130 million post-quarter, driven by new program wins such as the Falcon ManPAC. Management expects further gross margin improvements as operational initiatives at Newark and Raynham mature.
- Revenue growth supported by backlog conversion and new product launches.
- Gross margin expansion from operational efficiencies and favorable product mix.
For full-year 2026, Ultralife maintains its strategic priorities of expanding communication systems revenue, enhancing battery segment margins, advancing vertical integration, and completing brand consolidation, all expected to drive sustainable profitability and growth.
Takeaways
Ultralife’s Q2 2026 results reflect a company navigating a complex transition with encouraging signs of operational leverage and commercial traction in growth areas.
- Robust Backlog as Growth Indicator: The record $117.5 million backlog, growing 39% year-over-year, signals strong demand and execution on new product commercialization, providing revenue visibility into 2027.
- Operational Improvements Driving Margins: Margin gains are supported by both non-recurring tariff refunds and substantive operational initiatives, indicating management’s focus on profitability beyond cyclical factors.
- Strategic Diversification and Innovation: Investments in communication systems and vertical integration position Ultralife to reduce commercial cyclicality and capture emerging defense and specialized commercial markets.
Conclusion
Ultralife’s Q2 performance demonstrates effective execution on strategic priorities amidst a mixed revenue environment. The combination of backlog growth, margin improvement initiatives, and product innovation under a unified brand sets a foundation for sustained growth and enhanced profitability. Investors should monitor the conversion of backlog to revenue and the realization of operational efficiencies as key indicators of future success.
Industry Read-Through
Ultralife’s results highlight broader industry trends of defense-driven demand growth coupled with commercial market volatility, particularly in energy and battery sectors. The emphasis on ruggedized communication and edge computing solutions reflects increasing government investment in advanced tactical technologies. Operational margin improvement through lean manufacturing and vertical integration is becoming a critical competitive lever in battery and portable power industries. Other companies in defense electronics and battery manufacturing should note the importance of diversified product portfolios and brand clarity to navigate geopolitical and market uncertainties.